Nutritional care of surgical infants and children is of major importance. This is for several reasons: (i) body stores are often smaller and more precarious; (ii) infants and children not only require energy for maintenance, but also for growth; and (iii) as in adults, recovery from surgery is faster in those patients who are adequately nourished. Survival of infants with congenital anomalies dramatically improved following the introduction of parenteral nutrition. However, infection and cholestasis remain problematic for parenterally fed infants and children. 
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Background
Nutrition is especially important to surgical infants and children, firstly because of smaller body stores and relatively higher energy expenditure, and secondly because of the requirement for growth and adequate neurodevelopment. Energy stores are only adequate for ~2 days at 24-25 weeks gestation, increase to ~20 days at term as glycogen and fat stores increase (1) and are in excess of 50 days in the adult, hence the urgent need for adequate caloric intake in preterm infants after birth. Full-term neonates have higher content of endogenous fat (approximately 600g) and therefore can tolerate a few days of undernutrition. Nevertheless, adequate nutrition in excess of basic requirements, i.e. enough to support growth, should be instituted as soon as practicable. Although adults following surgery or trauma have increased energy requirements (2) , there is no strong evidence that increased energy should be provided to septic or surgical neonates (3), or to older children requiring surgery. Target enteral calories are as indicated in Table 1 .
The optimum nutritional route is oral enteral feeding, however, artificial enteral feeding or parenteral nutrition (PN) may be required if adequate oral feeds cannot be tolerated. The basic principle underlying choice of feeding routes is that the most physiological route safely possible should be used: gastric feeds are preferred over jejunal feeds, enteral feeds are preferred over parenteral feeds etc.
Growth monitoring
Artificial enteral nutrition and PN are both nutritional interventions, and nutritional outcomes should be assessed in order to determine the effectiveness of these interventions. Growth of all paediatric surgical patients, especially those receiving artificial nutritional support, should be monitored longitudinally using appropriate charts, currently the UK-WHO growth charts, 0-18 years available from the Royal College of Paediatrics and Child Health.
Artificial enteral feeding
Indications
The simplest artificial route likely to be encountered by paediatric surgeons is the naso-or oro-gastric tube given to premature infants for immaturity of swallowing. Other indications for artificial enteral feeds are: delayed gastric emptying, gastroesophageal reflux, impaired 4 
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intestinal motility, Crohn's disease, neurological or metabolic co-morbidity, intensive care/ventilation.
Route
The administration route can be naso-or oro-gastric or jejunal tubes, gastrostomy, gastrojejunostomy or surgical jejunostomy tubes. Gastric feeding is preferable to intestinal feeding because it allows for a more natural digestive process i.e. allows action of salivary and gastric enzymes and the antibacterial action of stomach acid, in addition to the use of the stomach as a reservoir. Gastric feeding is associated with a larger osmotic and volume tolerance and a lower frequency of diarrhoea and dumping syndrome. Thus, transpyloric feeds are usually restricted to infants or children (i) unable to tolerate naso-or oro-gastric feeds; (ii) at increased risk of aspiration; (iii) with anatomical contra-indications to gastric feeds. Neonates are obligatory nose breathers and therefore oro-gastric feeding may be preferable over naso-gastric feeding in preterm infants to avoid upper airway obstruction. However, naso-gastric tubes are easier to secure and may involve a lower risk of displacement. In infants requiring gastric tube feeding for extended periods (e.g. more than 6-8 weeks) it is advisable to insert a gastrostomy, to decrease the negative oral stimulation of repeated insertion of nasal or oral tubes. The tube can be inserted using an open, laparoscopic or percutaneous endoscopic (PEG) approach. In infants with significant gastro-oesophageal reflux, fundoplication with gastrostomy tube or enterostomy tube placement is indicated (4), although some authors favour gastrojejunal tube over fundoplication plus gastrostomy (5) . There is no strong evidence to prefer any of these therapeutic approaches over any other.
Selection of enteral feeds
Breast milk is the ideal feed for infants because it has specific anti-infectious activities, aids gastro-intestinal maturation and neurological development. When breast milk is not available chemically defined formulae can be used, which are designed either for preterm infants, term infants, or older children. If malabsorption is present and persists, an appropriate specific formula should be introduced, such as soy-based disaccharide-free feed for disaccharide intolerance, medium chain triglyceride (MCT) formula for fat malabsorption, elemental (free amino acids) or semi-elemental (protein hydrolysate containing di-and tri-peptides) formula for severe malabsorption due to short bowel syndrome or severe mucosal damage as in NEC.
For persistent severe malabsorption, a modular diet may be necessary, in which glucose, amino acid and MCT preparations are provided separately.
Administration of enteral feeds
Enteral feeds can be administered as boluses, continuous feeds or combination of the two. Bolus feeds are more physiological and stimulate intestinal motility, enterohepatic circulation of bile acids and gallbladder contraction. Bolus feeds mimic or supplement meals and are easier to administer than continuous feeds since a feeding pump is not required.
Where bolus feeds are not tolerated, for example in the presence of gastro-oesophageal reflux, continuous feeds should be administered via an infusion pump over 24 hours. Infants and children with jejunal tubes should receive continuous feeds and not bolus feeds as the stomach is no longer providing a reservoir.
Complications of enteral tube feeding
Complications can be mechanical including leakage, tube blockage, tube displacement or migration and intestinal perforation. Although infection is less of a risk than with PN, the risk of infected enteral feeds should not be ignored, and the gastrostomy/jejunostomy site can become infected. Other complications involve the gastrointestinal tract. These include:
gastro-oesophageal reflux with aspiration pneumonia, dumping syndrome and diarrhoea.
Jejunostomy tubes inserted at laparotomy can be also associated with intestinal obstruction.
In surgical infants and children, enteral feeding often results in vomiting, interruption of feeding, and inadequate calorie intake. In infants with congenital gastrointestinal anomalies, exclusive enteral feeding is commonly precluded for some time after surgery due to large gastric aspirates and intestinal dysmotility, so calorie intake is established initially by PN (see below). Enteral feeding is introduced when intestinal motility and absorption improves. The percentage of calories given enterally is gradually increased at the expense of intravenous calorie intake. This transition time from total PN to total enteral feeding could be quite long.
The presence of gastric aspirate often induces clinicians and surgeons not to use the gut for nutrition. However, minimal enteral feeding (trophic feeding) can be implemented early in these patients. These minimal feeds may prevent gut mucosal atrophy, increase intestinal blood flow, improve activity of digestive enzymes and thus 'prime' the gut for subsequent higher volume, nutritive feeds. Although enteral nutritional adequacy ('full enteral feeds') is usually assessed as enteral volume/calorie tolerance, it should be borne in mind that tolerance is not the same as absorption, as infants and children may require a significant period of time for intestinal adaptation to allow complete absorption of administered feeds. Growth monitoring following full enteral nutritional tolerance therefore remains necessary. In infants and children with stomas, frequent urinary electrolyte measurements are particularly 6 6 important. Low urinary sodium with normal serum sodium suggests active sodium conservation. As sodium is important for growth, sodium supplementation may be appropriate in this scenario (6) . 
Parenteral nutrition
Indications
Components of parenteral nutrition
The caloric needs for PN are provided by carbohydrate and lipid. Protein is required for growth and not used as a source of calories, since the catabolism of protein to produce energy is an uneconomic metabolic process compared to the oxidation of carbohydrate and fat which produces more energy at a lower metabolic cost. The ideal PN regimen therefore should provide 7 enough amino acids for protein turnover and tissue growth, and sufficient calories to minimise protein oxidation for energy.
Fluid requirements
The hydration and proportion of extracellular fluid changes rapidly in the neonate. In a surgical infant, these changes will also be occurring simultaneously with surgical intervention and initiation of PN. Fluid overload is a possibility in these infants, and careful consideration -amino acids (up to 3g/kg/d in infants, and 1.5-2.0g/kg/d in older children), In contrast to healthy adults who exist in a state of neutral nitrogen balance, infants and children need to be in positive nitrogen balance in order to achieve satisfactory growth and development. Preterm infants who are receiving glucose alone lose protein quickly (at the rate of 1-2% body protein per day), so should start to receive at least 1-1.5 g/kg/d amino acids parenterally if not receiving EN.
-electrolytes (sodium 2-4mmol/kg/d infants, 1-3 in children; potassium 0-3mmol/kg/d).
Other electrolytes (chloride, calcium, phosphate) are very dependent on the clinical condition of the patient and technical pharmacy aspects of stability and compounding, -Metabolic e.g. hyper or hypoglycaemia, hypertriglyceridaemia, electrolyte alterations.
-Fluid overload e.g. oedema, failure of closure of PDA.
-Infection -catheter, bacterial translocation etc. More than 50% of surgical infants on PN have at least one suspected episode of sepsis, and around 30% of surgical neonates having at least one positive blood culture (9, 10) . Although catheter-borne infections, which can be reduced by rigorous precautions, such chlorhexidine antisepsis (10) , are important, microbial translocation from the intestine is also a significant source of infection in surgical infants on PN.
-Cholestasis -The commonest hepatobiliary complication of PN is cholestasis (PN- Olive and Fish triglycerides. In addition to lipid management, careful management of these patients under a multi-disciplinary team seems to be beneficial (13) . Bowel lengthening procedures, such as the STEP procedure or longitudinal intestinal lengthening may help transition to enteral nutrition (14) , whereas in those with advanced liver disease and no prospect of enteral autonomy, transplantation may be considered.
Careful monitoring on patients on PN is mandatory. This is particularly important during the period over which PN is introduced. Full blood count, electrolytes, blood gases, urea/creatinine, glucose, calcium/phosphate, albumin, liver function tests (especially bilirubin), and cholesterol/triglycerides should all be monitored, together with vitamins and trace elements for long-term PN patients. PN should not be a "one size fits all" prescription, but individual tailoring is recommended, dependent on clinical status, monitoring results and introduction of enteral nutrition.
Conclusion and Future Directions
Nutrition of surgical infants and children is complicated by the requirement for growth.
Inadequate or unbalanced nutrition may lead to future problems for these children, and we are now able to start to improve nutrition delivery in order to optimise outcomes as well as survival.
Despite advances in nutritional care, such as the multi-disciplinary approach, complications such as sepsis and cholestasis remain relatively frequent. Future research should be aimed towards the prevention and treatment of these complications of artificial nutritional support.
